HU9202864D0 - Gycinamide derivatives, their production and pharmaceutical preparatives containing them - Google Patents

Gycinamide derivatives, their production and pharmaceutical preparatives containing them

Info

Publication number
HU9202864D0
HU9202864D0 HU922864A HU286492A HU9202864D0 HU 9202864 D0 HU9202864 D0 HU 9202864D0 HU 922864 A HU922864 A HU 922864A HU 286492 A HU286492 A HU 286492A HU 9202864 D0 HU9202864 D0 HU 9202864D0
Authority
HU
Hungary
Prior art keywords
gycinamide
derivatives
production
preparatives containing
pharmaceutical preparatives
Prior art date
Application number
HU922864A
Other languages
Hungarian (hu)
Other versions
HU210581B (en
HUT61731A (en
Inventor
Jean-Dominique Bourzat
Marc Capet
Claude Cotrel
Claude Guyon
Franco Manfre
Gerard Roussel
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9002890A external-priority patent/FR2659324B1/en
Priority claimed from FR9003838A external-priority patent/FR2659966B1/en
Priority claimed from FR9011651A external-priority patent/FR2667066B2/en
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of HU9202864D0 publication Critical patent/HU9202864D0/en
Publication of HUT61731A publication Critical patent/HUT61731A/en
Publication of HU210581B publication Critical patent/HU210581B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU9202864A 1990-03-07 1991-03-05 Process for prep. of glycinamide deriv.s and pharmaceutical compn.s contg. them HU210581B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9002890A FR2659324B1 (en) 1990-03-07 1990-03-07 N-HETEROCYCLYL GLYCINAMIDES, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM.
FR9003838A FR2659966B1 (en) 1990-03-26 1990-03-26 N-ARALKYL GLYCINAMIDE DERIVATIVES, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM.
FR9011651A FR2667066B2 (en) 1990-03-07 1990-09-21 N-HETEROCYCLYL GLYCINAMIDES, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM.

Publications (3)

Publication Number Publication Date
HU9202864D0 true HU9202864D0 (en) 1992-11-30
HUT61731A HUT61731A (en) 1993-03-01
HU210581B HU210581B (en) 1995-05-29

Family

ID=27252167

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9202864A HU210581B (en) 1990-03-07 1991-03-05 Process for prep. of glycinamide deriv.s and pharmaceutical compn.s contg. them

Country Status (10)

Country Link
EP (1) EP0518961A1 (en)
JP (1) JPH05504968A (en)
AU (1) AU650261B2 (en)
CA (1) CA2074357A1 (en)
HU (1) HU210581B (en)
IE (1) IE910745A1 (en)
IL (1) IL97475A0 (en)
NZ (1) NZ237339A (en)
PT (1) PT96970A (en)
WO (1) WO1991013874A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696475B2 (en) 1997-04-22 2004-02-24 Neurosearch A/S Substituted phenyl derivatives, their preparation and use
US6706749B2 (en) 1998-10-22 2004-03-16 Neurosearch A/S Substituted phenyl derivatives, their preparation and use

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658518B1 (en) * 1990-02-19 1992-04-30 Rhone Poulenc Sante N-PHENYL N-ALCOXYCARBONYLALKYLE GLYCINAMIDES, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM.
FR2695641B1 (en) * 1992-09-11 1994-11-25 Rhone Poulenc Rorer Sa (3-amino phenyl) -1 optically active hydroquinine ethanesulfonate, its preparation and its use.
EP0746544B1 (en) * 1994-02-22 1998-09-09 Merrell Pharmaceuticals Inc. Novel indole derivatives useful to treat estrogen-related neoplasms and disorders
FR2723739B1 (en) * 1994-08-19 1997-02-14 Sanofi Sa GLYCINAMIDE DERIVATIVES, METHODS FOR THEIR PREPARATION AND MEDICINAL PRODUCTS CONTAINING THEM.
WO1996039385A1 (en) 1995-06-06 1996-12-12 Pfizer Inc. Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
MX9709875A (en) * 1995-06-06 1998-03-31 Pfizer Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors.
KR100241643B1 (en) 1995-06-06 2000-03-02 디. 제이. 우드 Substituted N- (indole-2-carbonyl) -β-alanimamide and its derivatives for treating diabetes
US6277877B1 (en) 2000-08-15 2001-08-21 Pfizer, Inc. Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors
US7074805B2 (en) * 2002-02-20 2006-07-11 Abbott Laboratories Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
DE60325834D1 (en) * 2002-02-20 2009-03-05 Abbott Lab CONDENSED AZABICYCLIC COMPOUNDS AS INHIBITORS OF VANILLOID RECEPTOR 1 (VR1)
US6933311B2 (en) 2003-02-11 2005-08-23 Abbott Laboratories Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
US7767705B2 (en) 2006-08-25 2010-08-03 Abbott Laboratories Compounds that inhibit TRPV1 and uses thereof
EP2450346A1 (en) 2006-12-20 2012-05-09 Abbott Laboratories Antagonists of the TRPV1 receptor and uses thereof
JP2011515414A (en) 2008-03-20 2011-05-19 アボット・ラボラトリーズ Methods of making central nervous system drugs that are TRPV1 antagonists
CN114181133B (en) * 2021-11-24 2023-04-28 上海应用技术大学 Preparation method of glycine derivative acetamide compound

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166355A2 (en) * 1984-06-26 1986-01-02 Merck & Co. Inc. Substituted aminophenyl compounds and acylaminophenyl compounds and pharmaceutical compositions containing them
US4814463A (en) * 1985-12-31 1989-03-21 Biomeasure, Inc. CCK antagonists
FR2624698A1 (en) * 1987-12-18 1989-06-23 Bernard Lyon I Universite Clau HETEROCYCLIC DERIVATIVES OF N-CARBAMOYL-, N-THIOCARBAMOYL- OR N-AMIDINO-AMINOMALONYL OR AMINOSUCCINYL AMIDES USEFUL AS SULFURING AGENTS
EP0336356A3 (en) * 1988-04-05 1991-09-25 Abbott Laboratories Derivatives of tryptophan as cck antagonists
CA1326108C (en) * 1988-04-12 1994-01-11 Sun Hyuk Kim Cck antagonists
FR2658518B1 (en) * 1990-02-19 1992-04-30 Rhone Poulenc Sante N-PHENYL N-ALCOXYCARBONYLALKYLE GLYCINAMIDES, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM.
FR2667864B2 (en) * 1990-03-07 1994-08-05 Rhone Poulenc Sante N-PHENYL GLYCINAMIDE DERIVATIVES, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696475B2 (en) 1997-04-22 2004-02-24 Neurosearch A/S Substituted phenyl derivatives, their preparation and use
US6706749B2 (en) 1998-10-22 2004-03-16 Neurosearch A/S Substituted phenyl derivatives, their preparation and use

Also Published As

Publication number Publication date
EP0518961A1 (en) 1992-12-23
HU210581B (en) 1995-05-29
IL97475A0 (en) 1992-06-21
WO1991013874A1 (en) 1991-09-19
CA2074357A1 (en) 1991-09-08
HUT61731A (en) 1993-03-01
IE910745A1 (en) 1991-09-11
AU650261B2 (en) 1994-06-16
JPH05504968A (en) 1993-07-29
PT96970A (en) 1991-10-31
NZ237339A (en) 1992-10-28
AU7454191A (en) 1991-10-10

Similar Documents

Publication Publication Date Title
IL98472A0 (en) Dialkoxy-pyridinyl-benzimidazole derivatives,process for their preparation and their pharmaceutical use
IL106141A0 (en) Thiazolylvinylphenyl derivatives,their manufacture and pharmaceutical compositions containing them
ZA908157B (en) Pharmaceutical phenylpyridone derivatives
ZA914296B (en) Dialkoxy-pyridinyl-benzimidazole derivatives,process for their preparation and their pharmaceutical use
IL89881A0 (en) Peptide derivatives,their production and pharmaceutical compositions containing them
EP0449196A3 (en) Indole derivatives, their production and use
EP0429341A3 (en) Heterocyclic derivatives, their preparation and pharmaceuticals containing them
EP0288973A3 (en) Benzothiazolinone derivatives, their production and pharmaceutical composition
HU9202864D0 (en) Gycinamide derivatives, their production and pharmaceutical preparatives containing them
HU913050D0 (en) 1,3-benzoxasine derivatives, production and application thereof
HU913137D0 (en) 2-amino-4-carboxamido-pirimidine derivatives, their production and medical use
IL94450A0 (en) Benzocycloalkane derivatives and production thereof
HUP9901376A3 (en) 1-methylcarbapenem derivatives, their use, production thereof and medicaments containing the same
IL88927A0 (en) Thienoazepines,their production and pharmaceutical compositions containing them
EG19340A (en) Iminothiazoline derivatives, their production and herbicides containing them
CS265391A3 (en) Novel thienodiazepines, process for their preparation and pharmaceutical comprising them
IL85722A0 (en) Propiolophenone derivatives,their manufacture and pharmaceutical compositions containing them
IL102362A0 (en) 4-amino-3-hydroxycarboxylic acid derivatives,their production and pharmaceutical compositions containing them
IL99294A0 (en) Indolonaphthyridines,their production and pharmaceutical compositions containing them
IL91246A0 (en) Benzodiazepine compounds,their production and pharmaceutical compositions containing them
IL90958A0 (en) Cycloalkylthiazole derivatives,their manufacture and pharmaceutical compositions containing them
EP0488220A3 (en) Pyridone derivatives, and their production and use
EP0431953A3 (en) Pyrrolopyrimidine derivatives, their production and use
IL97321A0 (en) Diamine derivatives,their manufacture and pharmaceutical compositions containing them
EP0488009A3 (en) Piperidinoalkyl-benzoxazine-and-thiazine-compounds, processes for their preparation and drugs containing them

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee